Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v9-FR | Version v7-FR | |
---|---|---|
Language | French | French |
Date Updated | 2018-11-29 | 2018-05-28 |
Drug Identification Number | 02126745 | 02126745 |
Brand name | AMINOSYN II | AMINOSYN II |
Common or Proper name | Aminosyn™ II 15% Amino Acid for Injection (Sulfite-free) | Aminosyn™ II 15% Amino Acid for Injection (Sulfite-free) |
Company Name | ICU MEDICAL CANADA INC | ICU MEDICAL CANADA INC |
Ingredients | HISTIDINE TRYPTOPHAN N-ACETYL-L-TYROSINE L-LYSINE L-ALANINE METHIONINE GLYCINE GLUTAMIC ACID L-PROLINE L-ARGININE L-VALINE L-ASPARTIC ACID L-THREONINE L-PHENYLALANINE L-LEUCINE L-ISOLEUCINE SERINE | HISTIDINE TRYPTOPHAN N-ACETYL-L-TYROSINE L-LYSINE L-ALANINE METHIONINE GLYCINE GLUTAMIC ACID L-PROLINE L-ARGININE L-VALINE L-ASPARTIC ACID L-THREONINE L-PHENYLALANINE L-LEUCINE L-ISOLEUCINE SERINE |
Strength(s) | 450MG 300MG 405MG 1.575G 1.49G 258MG 750MG 1.107G 1.083G 1.527G 750MG 1.05G 600MG 447MG 1.5G 990MG 795MG | 450MG 300MG 405MG 1.575G 1.49G 258MG 750MG 1.107G 1.083G 1.527G 750MG 1.05G 600MG 447MG 1.5G 990MG 795MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 2000ML | 2000ML |
ATC code | B05BA | B05BA |
ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-06-05 | 2017-06-05 |
Actual start date | 2017-06-05 | 2017-06-05 |
Estimated end date | 2019-01-31 | 2019-01-31 |
Actual end date | 2018-10-31 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |